hepatocellular-carcinoma

Documents about hepatocellular-carcinoma

• Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial#863545ClinicalTrials.gov
• Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil#880637ClinicalTrials.gov
• Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation#900882ClinicalTrials.gov
• Biomarker and Mechanism Study of Systemic Therapy in Unresectable HCC#903192ClinicalTrials.gov
• FMT in IT-refractory HCC - FAB-HCC Pilot Study#909968ClinicalTrials.gov
• A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer#887242ClinicalTrials.gov
• A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors#911909ClinicalTrials.gov
• Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study#850211ClinicalTrials.gov
• Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular Carcinoma#841228ClinicalTrials.gov
• Drug-eluting Bead Transarterial Chemoembolisation (DEB-TACE) Versus (VS) Conventional Transarterial Chemoembolisation (cTACE) for Unresectable Hepatocellualr Carcinoma (HCC)#870039ClinicalTrials.gov
• The role of SPP1 in evaluating the prognosis, immune infiltration, and drug sensitivity of hepatocellular carcinoma#130410Unpaywall
• Secretory Lysosome‐Related Gene Signature Defines the Immune Microenvironment and Identifies RGS2 as a Prometastatic Factor in Hepatocellular Carcinoma.#193475NCBI PubMed Central
• Targeting the TIGIT/CD155-induced metabolic checkpoint in NK cells restores anti-tumor immunity and suppresses hepatocellular carcinoma growth.#199147NCBI PubMed Central
• Performance of GPT-based large language models in hepatocellular carcinoma stratification: liver function assessment, BCLC staging, and treatment recommendations.#281110NCBI PubMed Central
• Prediction of Ki-67 expression in hepatocellular carcinoma: a dual-center study based on T2-weighted imaging habitat analysis.#319105NCBI PubMed Central
• Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors#363618ClinicalTrials.gov
• HEMATOLOGICAL PARAMETERS IN HEPATOCELLULAR CARCINOMA AND microRNA-223 GENE ASSOCIATED WITH HEPATITIS VIRUS IN LOCAL AREA#619359CyberLeninka
• Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of patients with hepatocellular carcinoma.#659857NCBI PubMed Central
• A Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer#801254ClinicalTrials.gov
• Evaluate the Safety and Efficacy of Toripalimab Combined With Bevacizumab Versus Sorafenib Therapy for HCC#802186ClinicalTrials.gov
• Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer#837799ClinicalTrials.gov
• The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities#842149ClinicalTrials.gov
• HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC#848978ClinicalTrials.gov
• Camrelizumab Utilization on Patients With Advanced Liver Cancer#849501ClinicalTrials.gov
• A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC#863433ClinicalTrials.gov
• The Short-term Efficacy of Novel NTDP-RFA in the Treatment of Small HCC With Cirrhosis.#884802ClinicalTrials.gov
• Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)#888217ClinicalTrials.gov
• Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection#889656ClinicalTrials.gov
• Circulating Tumor Cell Capture for Early Diagnosis and Postoperative Tumor Recurrence Monitoring of Liver Cancer#889857ClinicalTrials.gov
• Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer#896923ClinicalTrials.gov
• Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease#903184ClinicalTrials.gov
• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors#825504ClinicalTrials.gov
• Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations#905128ClinicalTrials.gov
• Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax#162462ClinicalTrials.gov
• A multi-omics framework for survival mediation analysis of high-dimensional proteogenomic data#136458PLOS
• Liver and Spleen Stiffness to Predict the Presence of Esaphageal Varices in Cirrhotic With Advanced HCC#143709ClinicalTrials.gov
• Patient-derived organotypic tumor spheroids as a functional platform for predicting immunotherapeutic responses and guiding precision treatment for hepatocellular carcinoma.#156873NCBI PubMed Central
• PTM-Related Signatures Predict Lymph Node Metastasis and Shape Microenvironment in Hepatocellular Carcinoma: A Single-Cell and Bulk Integrated Analysis.#425118NCBI PubMed Central
• Integrative Multiomics Analysis Reveals a Cancer Stem Cell-Driven Prognostic Signature and Nominates Belinostat for Targeted Therapy in Hepatocellular Carcinoma.#427731NCBI PubMed Central
• Hepatocellular Carcinoma#486867Directory of Open Access Books
• Intra-tumoral epigenetic heterogeneity and aberrant molecular clocks in hepatocellular carcinoma#658839Europe PMC
• Transcriptional regulation of ubiquitin specific peptidase 2b by farnesoid X receptor and its implications in the pathogenesis of hepatocellular carcinoma.#685710NCBI PubMed Central
• Pan-cancer analysis identifies KANSL2 as a cell-cycle-associated regulator of tumor progression and immunity in liver hepatocellular carcinoma.#785586NCBI PubMed Central
• Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCC#804538ClinicalTrials.gov
• Envafolimab, Lenvatinib Combined With TACE in the Treatment of Unresectable Locally Advanced Hepatocellular Carcinoma#806638ClinicalTrials.gov
• The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy#807552ClinicalTrials.gov
• Anti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCC#807994ClinicalTrials.gov
• A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice#810952ClinicalTrials.gov
• Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies#825248ClinicalTrials.gov
• Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT#838492ClinicalTrials.gov